ATI RN
ATI Pharmacology Final Exam I Questions
Extract:
Question 1 of 5
A home health nurse is assessing an older adult client in the home who has decreased vision due to a history of glaucoma. Which of the following findings should the nurse identify as a safety risk?
Correct Answer: D
Rationale: Scatter rugs pose a major fall risk, especially for visually impaired clients. Removing or securing them enhances safety and reduces accident risk.
Question 2 of 5
A nurse is caring for a client who has a hip fracture that requires surgical repair. Which of the following health care professionals is responsible for obtaining informed consent from the client for the procedure?
Correct Answer: C
Rationale: The Surgeon is the healthcare professional who performs the surgical procedure. It is their responsibility to obtain informed consent from the patient.
Question 3 of 5
A nurse is providing teaching to a client about measures to prevent urinary tract infections (UTIs). Which client statement indicates a need for further teaching?
Correct Answer: B
Rationale: Wiping the perineal area from back to front after urination is incorrect. This technique can spread bacteria from the anal area to the urethra, increasing the risk of UTIs.
Question 4 of 5
A nurse is caring for a client receiving phenazopyridine (Azo) for urinary tract analgesia. Which of the following side effects is associated with phenazopyridine?
Correct Answer: C
Rationale: Orange-colored urine is a well-known and harmless side effect of phenazopyridine. This medication is used to relieve pain, burning, and discomfort in the urinary tract, and one of its notable effects is the discoloration of urine.
Question 5 of 5
A nurse is caring for a client with an elevated serum potassium level of 6.0 mEq/L (3.5-5.0 mEq/L). Which scheduled medication should the nurse plan to administer?
Correct Answer: D
Rationale: Sodium polystyrene sulfonate is a cation-exchange resin that is specifically used to treat hyperkalemia. It works by binding to potassium in the gastrointestinal tract, which is then excreted through the feces. This process effectively lowers serum potassium levels. Given its mechanism of action and its specific indication for treating hyperkalemia, sodium polystyrene sulfonate is the appropriate choice for a patient with an elevated potassium level of 6.0 mEq/L.